|
|
|
Welcome to IPOhome!
|
 |
 |
 |
|
|
|
| • |
Elixir Pharmaceuticals withdraws IPO [more] |
| • |
Biopharmaceutical company Aldagen files for IPO [more] |
| • |
Western Gas Partners L.P. prices below range [more] |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Sunday, May 11, 2008
|
|
|
 |
|
|
|
|
|
|
|
Week of May 12 - Upcoming
|
|
|
|
|
|
|
|
|
|
|
|
Privacy Policy | Business Continuity Planning | Anti-Money Laundering Policies |
© Renaissance Capital LLC. All rights reserved.
|
*-10.47%, 13.28% and -1.96% were the IPO Fund's one-, five- and ten-year average annual total returns through 3/31/2008. Past performance is no guarantee of future results. Investment return and principal value will vary. An investor's shares, when redeemed, may be worth more or less than original cost.
This web site should not be considered a solicitation or offering for the shares of IPO Plus Aftermarket Fund (IPO Plus Fund) in any country in which the Fund is not registered. The Fund is offered by prospectus only. The prospectus contains more complete information including fees, expenses and risks involved in investing in initial public offerings and should be read carefully before investing. Shares of the IPO Plus Fund are available for direct sale only in the United States and Puerto Rico.
The IPO Plus Aftermarket Fund's code of ethics is available to its shareholders free of charge. To obtain a copy, shareholders may call the Fund toll-free, 1-888-476-3863.
|
|
2008 1st Quarter IPO Review
